Literature DB >> 9301545

Cytokine research: the interferon paradigm.

A Morris1, I Zvetkova.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9301545      PMCID： PMC500100          DOI： 10.1136/jcp.50.8.635

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  35 in total

Review 1.  The interferon system. A bird's eye view of its biochemistry.

Authors:  G C Sen; P Lengyel
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

Review 2.  Therapeutic advances: beta-interferon for multiple sclerosis.

Authors:  W Clark
Journal:  J Clin Pharm Ther       Date:  1996-08       Impact factor: 2.512

3.  "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation.

Authors:  D C Dumonde; R A Wolstencroft; G S Panayi; M Matthew; J Morley; W T Howson
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

Review 4.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

6.  A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells.

Authors:  S Hemmi; R Böhni; G Stark; F Di Marco; M Aguet
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

7.  Interaction between the components of the interferon gamma receptor complex.

Authors:  S V Kotenko; L S Izotova; B P Pollack; T M Mariano; R J Donnelly; G Muthukumaran; J R Cook; G Garotta; O Silvennoinen; J N Ihle
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

8.  Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells.

Authors:  J F Wedgwood; L Hatam; V R Bonagura
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

9.  Involvement of the IRF-1 transcription factor in antiviral responses to interferons.

Authors:  T Kimura; K Nakayama; J Penninger; M Kitagawa; H Harada; T Matsuyama; N Tanaka; R Kamijo; J Vilcek; T W Mak
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307
View more
  4 in total

1.  Sensitivities of human monocytes and epithelial cells to pneumolysin are different.

Authors:  Robert A Hirst; Hasan Yesilkaya; Edwin Clitheroe; Andrew Rutman; Nichola Dufty; Timothy J Mitchell; Christopher O'Callaghan; Peter W Andrew
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.

Authors:  Eri Ishikawa; Masatoshi Nakazawa; Masahiro Yoshinari; Mutsuhiko Minami
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children.

Authors:  Qibo Zhang; Jolanta Bernatoniene; Linda Bagrade; James C Paton; Timothy J Mitchell; Sven Hammerschmidt; Desmond A Nunez; Adam Finn
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs.

Authors:  N Kayagaki; N Yamaguchi; M Nakayama; H Eto; K Okumura; H Yagita
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.